Based on the previous evidence, we examined whether IDH1 knockdown could potentially accelerate the invasion ability of breast cancer cells through MAPK–HIF-1a/NFkB signaling (Additional file 10: Figure S6b). Here, IDH1 is linked to breast carcinoma.